Randomised clinical trial of early specialist palliative care plus standard care versus standard care alone in patients with advanced cancer: The Danish Palliative Care Trial

Abstract

Background:

Beneficial effects of early palliative care have been found in advanced cancer, but the evidence is not unequivocal.

Aim:

To investigate the effect of early specialist palliative care among advanced cancer patients identified in oncology departments.

Setting/participants:

The Danish Palliative Care Trial (DanPaCT) (ClinicalTrials.gov NCT01348048) is a multicentre randomised clinical trial comparing early referral to a specialist palliative care team plus standard care versus standard care alone. The planned sample size was 300. At five oncology departments, consecutive patients with advanced cancer were screened for palliative needs. Patients with scores exceeding a predefined threshold for problems with physical, emotional or role function, or nausea/vomiting, pain, dyspnoea or lack of appetite according to the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) were eligible. The primary outcome was the change in each patient’s primary need (the most severe of the seven QLQ-C30 scales) at 3- and 8-week follow-up (0–100 scale). Five sensitivity analyses were conducted. Secondary outcomes were change in the seven QLQ-C30 scales and survival.

Results:

Totally 145 patients were randomised to early specialist palliative care versus 152 to standard care. Early specialist palliative care showed no effect on the primary outcome of change in primary need (−4.9 points (95% confidence interval −11.3 to +1.5 points); p = 0.14). The sensitivity analyses showed similar results. Analyses of the secondary outcomes, including survival, also showed no differences, maybe with the exception of nausea/vomiting where early specialist palliative care might have had a beneficial effect.

Conclusion:

We did not observe beneficial or harmful effects of early specialist palliative care, but important beneficial effects cannot be excluded.

Keywords

Palliative care advanced cancer randomised clinical trial quality of life needs assessment patient satisfaction EORTC QLQ-C30

Get full access to this article

View all access options for this article.

References

Zimmermann

Swami

Krzyzanowska

et al . Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014; 383: 1721–1730.

Groenvold

Hansen

Rasmussen

Danish palliative care database: annual report 2011. Copenhagen: DMCG-PAL, 2012.

Johnsen

Petersen

Pedersen

et al . Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med 2009; 23: 491–501.

Johnsen

Petersen

Pedersen

et al . Do advanced cancer patients in Denmark receive the help they need? A nationally representative survey of the need related to 12 frequent symptoms/problems. Psychooncology 2013; 22: 1724–1730.

Sanson-Fisher

Girgis

Boyes

et al . The unmet supportive care needs of patients with cancer. Supportive Care Review Group. Cancer 2000; 88: 226–237.

Harrison

Young

Price

et al . What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer 2009; 17: 1117–1128.

World Health Organization. National cancer control programmes: policies and managerial guidelines. 2nd ed. Geneva: World Health Organization, 2002.

Kavalieratos

Corbelli

Zhang

et al . Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 2016; 316: 2104–2114.

Temel

Greer

Muzikansky

et al . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733–742.

10.

Bakitas

Tosteson

et al . Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015; 33: 1438–1445.

11.

Bakitas

Lyons

Hegel

et al . Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 2009; 302: 741–749.

12.

McCorkle

Jeon

Ercolano

et al . An advanced practice nurse coordinated multidisciplinary intervention for patients with late-stage cancer: a cluster randomized trial. J Palliat Med 2015; 18: 962–969.

13.

Temel

Greer

El-Jawahri

et al . Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol 2017; 35: 834–841.

14.

Bakitas

Lyons

Hegel

et al . The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat Support Care 2009; 7: 75–86.

15.

Dionne-Odom

Azuero

Lyons

et al . Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol 2015; 33: 1446–1452.

16.

Maltoni

Scarpi

Dall’Agata

et al . Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. Eur J Cancer 2016; 65: 61–68.

17.

Smith

Temin

Alesi

et al . American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30: 880–887.

18.

Ferrell

Temel

Temin

et al . Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2017; 35: 96–112.

19.

Johnsen

Damkier

Vejlgaard

et al . A randomised, multicentre clinical trial of specialised palliative care plus standard treatment versus standard treatment alone for cancer patients with palliative care needs: the Danish palliative care trial (DanPaCT) protocol. BMC Palliat Care 2013; 12: 37.

20.

Johnsen

Petersen

Gluud

et al . Detailed statistical analysis plan for the Danish Palliative Care Trial (DanPaCT). Trials 2014; 15: 376.

21.

Radbruch

Payne

White Paper on standards and norms for hospice and palliative care in Europe: part 1. Recommendations from the European Association for Palliative Care. Eur J Pall Care 2009; 16: 278–289.

22.

American Joint Committee on Cancer. AJCC cancer staging manual. Chicago, IL: Springer, 2010.

23.

Aaronson

Ahmedzai

Bergman

et al . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.

24.

Fayers

Aaronson

Bjordal

et al . The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: European Organization for Research and Treatment of Cancer, 2001.

25.

Gotzsche

PC.

Blinding during data analysis and writing of manuscripts. Control Clin Trials 1996; 17: 285–290.

26.

Jarvinen

Sihvonen

Bhandari

et al . Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol 2014; 67: 769–772.

27.

SAS Institute, Inc. SAS/STAT(R) 9.3 user’s guide. Cary, NC: SAS Institute, Inc., 2011.

28.

Johnson

VE.

Revised standards for statistical evidence. Proc Natl Acad Sci U S A 2013; 110: 19313–19317.

29.

Jakobsen

Gluud

Winkel

et al . The thresholds for statistical and clinical significance – a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol 2014; 14: 34.

30.

Jackson

Jacobsen

Greer

et al . The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide. J Palliat Med 2013; 16: 894–900.

31.

Velikova

Coens

Efficace

et al . Health-related quality of life in EORTC clinical trials – 30 years of progress from methodological developments to making a real impact on oncology practice. Eur J Cancer Suppl 2012; 10: 141–149.

32.

Smith

Cocks

Parry

et al . Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G). Qual Life Res 2014; 23: 971–976.